Arfah Hazel Preston
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Arfah Hazel Preston has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Judy Archer
Pinderfields General Hospital Aberford Road Wakefield WF1 4DG UK
1 shared publication- Stefan Williams
Leeds Teaching Hospitals NHS Trust
1 shared publication
Latest Publications
- Open Access
- 13 April 2016
- Published by Wiley in Clinical Case Reports
- Vol. 4 (5) , 513-516
A review of the role of anticoagulation for patients with infective endocarditis and embolic stroke
Key Clinical Message: Stroke is a common embolic complication of infective endocarditis. The most important treatment to prevent stroke in endocarditis is the initiation of antibiotic therapy. It is unclear whether the initiation of de novo anticoagulation (i.e, warfarin) in patients with infective endocarditis is beneficial, since there are no large or randomized controlled trials in this area. However, this case report suggests, despite the limited evidence, that anticoagulation in this patient caused no harm and could suggest a hint of possible benefit.
- 13 April 2016
- Published by Wiley in Clinical Case Reports
- Vol. 4 (5) , 513-516
Open AccessA review of the role of anticoagulation for patients with infective endocarditis and embolic stroke
Key Clinical Message: Stroke is a common embolic complication of infective endocarditis. The most important treatment to prevent stroke in endocarditis is the initiation of antibiotic therapy. It is unclear whether the initiation of de novo anticoagulation (i.e, warfarin) in patients with infective endocarditis is beneficial, since there are no large or randomized controlled trials in this area. However, this case report suggests, despite the limited evidence, that anticoagulation in this patient caused no harm and could suggest a hint of possible benefit.